➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

Patent: 8,216,091

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,216,091
Title:Sliding impulse device
Abstract: A structure motivated by an impulse to slide over a surface, including: an impulse-receiving portion for receiving the impulse, the impulse-receiving portion defining a section of a generally semi-hemispherical structure and produced from a foam material patterned to represent at least a portion of a sports ball; and a sliding portion, coupled to the impulse-receiving portion, for sliding contact with the surface on a contact surface of the sliding portion responsive to the impulse the contact surface having a generally planar smooth surface having a periphery surrounded by an extension of the impulse receiving portion, wherein a tumbling of a coupled combination of the impulse-receiving portion and the sliding portion is inhibited by shifting a center of gravity downward by a greater weighting of the sliding portion relative to the impulse-receiving portion.
Inventor(s): Neal; Phillip H. (San Rafael, CA), Nelson; Royce (Oakland, CA)
Assignee: Diggin Active, Inc. (Emeryville, CA)
Application Number:12/791,775
Patent Claims:see list of patent claims

Details for Patent 8,216,091

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Emergent Biosolutions Canada Inc. BAT botulism antitoxin heptavalent LIQUID 125462 1 2013-03-01   Start Trial Diggin Active, Inc. (Emeryville, CA) 2040-01-29 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.